📚 Study Resource

Peripheral Nerves and Muscles

Free Article

Enhance your knowledge with our comprehensive guide and curated study materials.

Apr 05, 2026 PDF Available

Topic Overview

🔶 PERIPHERAL NERVES AND MUSCLES

🔷 DISORDERS OF PERIPHERAL NERVES

🔹 STRUCTURE OF PERIPHERAL NERVE

🔸 Components

  • Axon

    • Extension of neuron

    • Conducts nerve impulse

    • Supported by Schwann cells

  • Myelin sheath (Schwann cells)

    • Lipid-rich insulating layer

    • Enables saltatory conduction

    • Nodes of Ranvier → rapid impulse transmission

  • Connective tissue layers

    • Endoneurium → surrounds individual fibers

    • Perineurium → surrounds fascicles (blood-nerve barrier ❗)

    • Epineurium → outer dense connective tissue

🧠 Diagram: Structure of Peripheral Nerve (VERY IMPORTANT)

Image

Image

Image

Image

🔹 CLASSIFICATION OF NEUROPATHIES

🔸 Based on distribution

  • Mononeuropathy

    • Single nerve involvement

    • Example → Carpal tunnel syndrome

  • Polyneuropathy

    • Symmetrical involvement

    • Distal → proximal progression

  • Mononeuritis multiplex

    • Multiple individual nerves affected

    • Asymmetric

  • Symmetric distal polyneuropathy (stocking-glove) ❗

    • Most common pattern

    • Seen in diabetes

🔸 Based on fiber type involvement

🔹 Small fiber neuropathy ❗

  • Affects:

    • Pain (C fibers)

    • Temperature

  • Features:

    • Burning pain

    • Normal reflexes

    • No muscle weakness

🔹 Large fiber neuropathy ❗

  • Affects:

    • Vibration

    • Proprioception

  • Features:

    • Sensory ataxia

    • Loss of reflexes

    • Motor weakness

🔸 Etiological classification

  • Metabolic

    • Diabetes mellitus ❗ (most common)

  • Toxic

    • Alcohol

    • Chemotherapy drugs

  • Infectious

    • Leprosy (segmental involvement)

  • Immune-mediated

    • Guillain-Barré syndrome

    • CIDP

  • Hereditary

    • Charcot-Marie-Tooth disease

📊 TABLE: TYPES OF NEUROPATHY (AXONAL vs DEMYELINATING)

Feature Axonal Neuropathy Demyelinating Neuropathy
Primary defect Axon damage Myelin sheath damage
Nerve conduction ↓ Amplitude ↓ Velocity ❗
Muscle atrophy Early Late
Reflexes Reduced Markedly reduced
Examples Diabetic neuropathy GBS, CIDP

📊 TABLE: SMALL FIBER vs LARGE FIBER NEUROPATHY ❗

Feature Small Fiber Large Fiber
Fibers C fibers Aα, Aβ
Function Pain, temperature Vibration, proprioception
Reflexes Normal Reduced
Weakness Absent Present
Symptoms Burning pain Ataxia

📊 TABLE: ETIOLOGY OF PERIPHERAL NEUROPATHY

Category Causes
Metabolic Diabetes
Toxic Alcohol, drugs
Infectious Leprosy
Immune GBS, CIDP
Hereditary CMT disease

📊 TABLE: MONONEUROPATHY vs POLYNEUROPATHY

Feature Mononeuropathy Polyneuropathy
Nerve involvement Single Multiple
Distribution Localized Symmetrical
Example Carpal tunnel Diabetic neuropathy

🧠 FLOWCHART: NERVE INJURY CLASSIFICATION

Nerve injury
↓
Axonal damage OR Myelin damage
↓
Axonal degeneration (Wallerian)
OR
Segmental demyelination
↓
Functional deficit
↓
Recovery / Regeneration / Chronic neuropathy

🧠 KEY CONCEPTS (HIGH-YIELD REVISION)

  • Stocking-glove pattern → Diabetes ❗

  • Demyelination → ↓ conduction velocity ❗

  • Axonal damage → ↓ amplitude ❗

  • Large fiber → Ataxia

  • Small fiber → Burning pain

  • Perineurium → Blood-nerve barrier ❗

🔬 CLINICAL CORRELATION

  • Diabetes → distal symmetric polyneuropathy

  • Leprosy → mononeuritis multiplex

  • GBS → acute demyelinating neuropathy

  • Alcohol → axonal neuropathy

 

🔷 PATTERNS OF PERIPHERAL NERVE INJURY

🔹 AXONAL DEGENERATION (WALLERIAN DEGENERATION)

🔸 Definition

  • Degeneration of axon distal to site of injury

  • Most common pattern of nerve injury

🔸 Pathogenesis (STEPWISE)

  • Axonal injury

  • Decreased axonal transport

  • Myelin breakdown

  • Macrophage-mediated clearance

  • Schwann cell proliferation

  • Formation of Bands of Büngner (guiding tubes for regeneration)

🧠 Diagram: Wallerian Degeneration (VERY IMPORTANT)

Image

Image

Image

Image

🔹 SEGMENTAL DEMYELINATION

🔸 Definition

  • Loss of myelin sheath without axonal damage

🔸 Causes

  • Immune-mediated (GBS, CIDP)

  • Toxins

  • Metabolic disorders

🔸 Features

  • Slowed nerve conduction

  • Reversible

  • Repeated cycles → onion bulb formation

🧠 Diagram: Myelin Damage

Image

Image

Image

Image

🔹 AXONAL REGENERATION

🔸 Requirements for regeneration

  • Intact endoneurial tubes

  • Viable Schwann cells

  • Short gap between nerve ends

🔸 Mechanism

  • Proximal stump sprouts new axons

  • Guided by Bands of Büngner

  • Reinnervation of target tissue

🧠 FLOWCHART: AXONAL REGENERATION

Axonal injury
↓
Wallerian degeneration (distal)
↓
Schwann cell proliferation
↓
Bands of Büngner formation
↓
Axonal sprouting (proximal stump)
↓
Guided regeneration
↓
Reinnervation / Functional recovery

🔹 DISTAL AXONOPATHY

🔸 Definition

  • Degeneration begins at distal end of axon

  • “Dying-back neuropathy”

🔸 Causes

  • Diabetes

  • Toxins (alcohol, drugs)

🔸 Features

  • Length-dependent

  • Stocking-glove distribution

🔹 NEURONOPATHY

🔸 Definition

  • Primary damage to neuron cell body

🔸 Causes

  • Viral infections

  • Toxins

🔸 Features

  • Widespread dysfunction

  • Sensory or motor neuron loss

📊 TABLE: AXONAL vs DEMYELINATING NEUROPATHY (VERY IMPORTANT)

Feature Axonal Neuropathy Demyelinating Neuropathy
Primary site Axon Myelin
Conduction velocity Normal/slightly decreased Markedly decreased
Amplitude Decreased Normal/mildly decreased
Muscle atrophy Early Late
Recovery Slow Faster
Examples Diabetes GBS, CIDP

🧠 FLOWCHART: WALLERIAN DEGENERATION

Nerve injury
↓
Axonal disruption
↓
Distal axon degeneration
↓
Myelin breakdown
↓
Macrophage clearance
↓
Schwann cell proliferation
↓
Bands of Büngner formation
↓
Preparation for regeneration

🔬 SLIDES (EXAM FAVORITE)

🔹 Demyelination (Thin Myelin Sheath)

Image

Image

Image

Image

  • Thin or absent myelin

  • Axon relatively preserved

  • Seen in GBS, CIDP

🔹 Onion Bulb Formation

Image

Image

Image

Image

  • Concentric layers of Schwann cells

  • Due to repeated demyelination–remyelination

  • Seen in chronic neuropathies (CIDP)

🧠 KEY HIGH-YIELD POINTS

  • Wallerian degeneration → distal axon degeneration

  • Bands of Büngner → essential for regeneration

  • Demyelination → decreased conduction velocity

  • Axonal damage → decreased amplitude

  • Onion bulb → chronic demyelination

  • Distal axonopathy → diabetes (most common)

 

🔷 DISORDERS ASSOCIATED WITH PERIPHERAL NERVE INJURY

🔹 DIABETIC NEUROPATHY

🔸 Definition

  • Most common form of peripheral neuropathy

  • Caused by chronic hyperglycemia

🔸 Pathogenesis

  • Polyol (sorbitol) pathway activation → osmotic injury

  • Advanced glycation end products (AGEs) → microvascular damage

  • Oxidative stress → nerve ischemia

  • Segmental demyelination + axonal degeneration

🔸 Clinical features

  • Distal symmetric polyneuropathy

  • Stocking-glove distribution

  • Sensory loss → pain, paresthesia

  • Reduced reflexes

🔹 GUILLAIN-BARRÉ SYNDROME (GBS)

🔸 Definition

  • Acute inflammatory demyelinating polyneuropathy

  • Rapidly progressive ascending paralysis

🔸 Pathogenesis

  • Autoimmune response (often post-infection)

  • Antibodies target peripheral nerve components

  • Complement activation → demyelination

🔸 Clinical features

  • Ascending weakness

  • Areflexia

  • Respiratory muscle involvement (severe cases)

🔹 GBS VARIANTS

🔸 AIDP (Acute Inflammatory Demyelinating Polyneuropathy)

  • Most common type

  • Demyelination predominant

🔸 AMAN (Acute Motor Axonal Neuropathy)

  • Axonal damage

  • Pure motor involvement

🔸 Miller-Fisher Syndrome

  • Triad:

    • Ataxia

    • Ophthalmoplegia

    • Areflexia

🔹 CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)

🔸 Definition

  • Chronic counterpart of GBS

🔸 Features

  • Slow progression

  • Relapsing-remitting course

  • Demyelination with remyelination

🔹 TOXIC NEUROPATHIES

🔸 Causes

  • Alcohol

  • Chemotherapy drugs

  • Heavy metals

🔸 Features

  • Axonal degeneration

  • Distal symmetric involvement

🔹 NUTRITIONAL NEUROPATHY

🔸 Causes

  • Vitamin B1 (thiamine) deficiency

  • Vitamin B12 deficiency

🔸 Features

  • Sensory neuropathy

  • Mixed axonal and demyelinating features

📊 TABLE: GBS vs CIDP

Feature GBS CIDP
Onset Acute Chronic
Course Rapid progression Slow progression
Pathology Demyelination Demyelination + remyelination
Recovery Often complete Partial/relapsing
Duration < 4 weeks > 8 weeks

📊 TABLE: GBS VARIANTS

Variant Pathology Features
AIDP Demyelination Most common
AMAN Axonal Pure motor
Miller-Fisher Immune-mediated Ataxia, ophthalmoplegia

📊 TABLE: CAUSES OF PERIPHERAL NEUROPATHY (EXPANDED)

Category Causes
Metabolic Diabetes
Toxic Alcohol, drugs
Infectious Leprosy
Immune GBS, CIDP
Nutritional Vitamin deficiency
Hereditary CMT disease

🧠 FLOWCHART: AUTOIMMUNE NEUROPATHY (GBS MECHANISM)

Trigger (infection)
↓
Immune activation
↓
Autoantibodies against nerve components
↓
Complement activation
↓
Myelin damage (demyelination)
↓
Conduction block
↓
Muscle weakness / paralysis

🧠 DIAGRAM: IMMUNE-MEDIATED DEMYELINATION

Image

Image

Image

Image

🔬 SLIDES (EXAM FAVORITE)

🔹 GBS – Inflammatory Infiltrates + Demyelination

Image

Image

Image

Image

  • Inflammatory cell infiltration (macrophages, lymphocytes)

  • Segmental demyelination

  • Axon relatively preserved in early stages

🧠 KEY HIGH-YIELD POINTS

  • Diabetes → most common neuropathy

  • GBS → acute ascending paralysis

  • CIDP → chronic demyelinating neuropathy

  • Miller-Fisher → ataxia + ophthalmoplegia + areflexia

  • AMAN → axonal variant

  • Demyelination → conduction block

 

🔷 DISORDERS OF NEUROMUSCULAR JUNCTION

🔹 STRUCTURE OF NEUROMUSCULAR JUNCTION

🔸 Components

  • Presynaptic terminal

    • Contains synaptic vesicles filled with acetylcholine (ACh)

    • Voltage-gated Ca²⁺ channels present

  • Synaptic cleft

    • Space between nerve and muscle

    • Contains acetylcholinesterase (AChE)

  • Postsynaptic membrane (motor end plate)

    • Junctional folds increase surface area

    • Contains ACh receptors (nicotinic type)

🧠 Diagram: Neuromuscular Junction (VERY IMPORTANT)

Image

Image

Image

Image

🔹 PHYSIOLOGY OF NEUROMUSCULAR TRANSMISSION

🔸 Stepwise mechanism

  • ACh synthesis

    • Choline + Acetyl-CoA → ACh (via choline acetyltransferase)

  • Vesicle storage

    • ACh stored in synaptic vesicles

  • Nerve impulse arrival

    • Depolarization of presynaptic membrane

  • Ca²⁺ mediated release

    • Opening of voltage-gated Ca²⁺ channels

    • Ca²⁺ influx → vesicle fusion → ACh release

  • Binding to receptors

    • ACh binds nicotinic receptors on postsynaptic membrane

  • End-plate potential

    • Na⁺ influx → depolarization

    • Generates muscle action potential

  • Termination

    • ACh broken down by acetylcholinesterase

🧠 Diagram: NM Transmission Physiology

Image

Image

Image

Image

🔹 TYPES OF NM JUNCTION DISORDERS

🔸 Pre-synaptic disorders

  • Defect in ACh release

  • Examples:

    • Lambert-Eaton syndrome

    • Botulism

🔸 Post-synaptic disorders

  • Defect in ACh receptors

  • Example:

    • Myasthenia gravis

🔹 MECHANISMS OF DYSFUNCTION

  • Reduced ACh synthesis

  • Impaired vesicle release

  • Blockade of Ca²⁺ channels

  • Destruction of ACh receptors

  • Increased degradation of ACh

📊 TABLE: NM JUNCTION DISORDERS CLASSIFICATION

Type Site of defect Mechanism Examples
Pre-synaptic Nerve terminal ↓ ACh release Lambert-Eaton, Botulism
Post-synaptic Motor end plate ACh receptor defect Myasthenia gravis

🧠 KEY HIGH-YIELD POINTS

  • Ca²⁺ influx → essential for ACh release

  • ACh receptor → nicotinic type

  • End-plate potential → triggers muscle contraction

  • Pre-synaptic disorders → ↓ ACh release

  • Post-synaptic disorders → receptor damage

  • AChE → terminates signal

 

🔷 MYASTHENIA GRAVIS

🔹 DEFINITION

  • Chronic autoimmune disorder of neuromuscular junction

  • Characterized by weakness of skeletal muscles due to impaired neuromuscular transmission

🔹 PATHOGENESIS

🔸 Core mechanism

  • Autoantibodies directed against postsynaptic ACh receptors (nicotinic type)

🔸 Key pathogenic events

  • Autoantibody binding to ACh receptors

  • Complement-mediated damage of postsynaptic membrane

  • Loss and degradation of ACh receptors

  • Simplification (flattening) of postsynaptic folds

  • Reduced end-plate potential → failure of neuromuscular transmission

🔸 Thymus association

  • Thymic abnormalities present in most patients

    • Thymic hyperplasia (most common)

    • Thymoma

🧠 FLOWCHART: PATHOGENESIS OF MYASTHENIA GRAVIS

Autoimmune trigger
↓
Autoantibodies against ACh receptors
↓
Complement activation
↓
Postsynaptic membrane damage
↓
Loss of ACh receptors
↓
Reduced end-plate potential
↓
Impaired neuromuscular transmission
↓
Muscle weakness

🧠 Diagram: ACh Receptor Destruction Mechanism

Image

 

Image

Image

🔹 MORPHOLOGY

🔸 Neuromuscular junction

  • Decreased number of ACh receptors

  • Flattened postsynaptic folds

  • Widened synaptic cleft

🔸 Thymus

  • Hyperplasia with germinal centers

  • Thymoma in some patients

🔹 CLINICAL FEATURES

  • Fluctuating muscle weakness

  • Weakness worsens with activity

  • Improves with rest

  • Commonly affected muscles:

    • Extraocular → ptosis, diplopia

    • Facial muscles

    • Bulbar muscles (speech, swallowing)

  • Severe cases → respiratory failure (myasthenic crisis)

🔹 DIAGNOSIS

  • Detection of anti-ACh receptor antibodies

  • Electrophysiological studies

    • Repetitive nerve stimulation → decremental response

  • Edrophonium test (historical)

  • Imaging for thymoma

🔹 TREATMENT

  • Acetylcholinesterase inhibitors (e.g., pyridostigmine)

  • Immunosuppressive therapy (steroids)

  • Thymectomy

  • Plasmapheresis (severe cases)

📊 TABLE: MYASTHENIA GRAVIS vs LAMBERT-EATON SYNDROME

Feature Myasthenia Gravis Lambert-Eaton Syndrome
Site Postsynaptic Presynaptic
Antibody target ACh receptor Ca²⁺ channels
Muscle strength Worsens with activity Improves with activity
Reflexes Normal Reduced
Association Thymoma Small cell lung carcinoma

🔬 SLIDES (EXAM FAVORITE)

🔹 Thymic Hyperplasia

Image

 

Image

 

  • Enlarged thymus

  • Presence of germinal centers

  • Indicates autoimmune activity

🔹 Thymoma

Image

Image

 

  • Tumor of thymic epithelial cells

  • Mixed population of epithelial cells and lymphocytes

  • Associated with myasthenia gravis

🧠 KEY HIGH-YIELD POINTS

  • Autoantibodies against ACh receptors

  • Complement-mediated postsynaptic damage

  • Decreased ACh receptors → decreased transmission

  • Thymic hyperplasia common

  • Weakness worsens with activity

  • Improves with rest

  • Extraocular muscles commonly involved

 

🔷 LAMBERT–EATON SYNDROME

🔹 DEFINITION

  • Autoimmune disorder of neuromuscular junction

  • Characterized by impaired release of acetylcholine from presynaptic terminal

🔹 PATHOGENESIS

🔸 Core mechanism

  • Autoantibodies against voltage-gated Ca²⁺ channels (VGCC) in presynaptic membrane

🔸 Pathophysiology

  • Antibody-mediated blockade of Ca²⁺ channels

  • ↓ Ca²⁺ influx during nerve impulse

  • ↓ vesicle fusion → ↓ ACh release

  • Impaired neuromuscular transmission

🔹 ASSOCIATION

  • Strong association with small cell lung carcinoma (paraneoplastic syndrome)

🔹 CLINICAL FEATURES

  • Proximal muscle weakness

  • Autonomic symptoms:

    • Dry mouth

    • Impotence

  • Improvement with repeated use (facilitation phenomenon)

  • Reflexes reduced or absent

🧠 Diagram: Pre-synaptic Defect Mechanism

Image

Image

Image

Image

🧠 KEY HIGH-YIELD POINTS

  • Presynaptic defect

  • Anti–Ca²⁺ channel antibodies

  • ↓ ACh release

  • Associated with small cell lung carcinoma

  • Strength improves with repeated use

🔷 MISCELLANEOUS NM JUNCTION DISORDERS

🔹 DRUG-INDUCED DISORDERS

🔸 Mechanism

  • Interference with neuromuscular transmission

🔸 Examples

  • Aminoglycosides → inhibit ACh release

  • Neuromuscular blockers → receptor blockade

🔹 BOTULISM

🔸 Definition

  • Neuroparalytic illness caused by Clostridium botulinum toxin

🔸 Mechanism

  • Toxin blocks release of ACh from presynaptic terminal

  • Acts by cleaving SNARE proteins → prevents vesicle fusion

🧠 FLOWCHART: BOTULINUM TOXIN MECHANISM

Botulinum toxin exposure
↓
Entry into presynaptic terminal
↓
Cleavage of SNARE proteins
↓
Failure of vesicle fusion
↓
No ACh release
↓
Flaccid paralysis

🔹 CLINICAL FEATURES

  • Descending paralysis

  • Cranial nerve involvement

  • Respiratory failure (severe cases)

🧠 Diagram: Block of ACh Release

 

https://www.researchgate.net/publication/394654555/figure/fig1/AS%3A11431281703351757%401761723246168/Mechanism-of-action-of-botulinum-toxin-type-A-at-the-neuromuscular-junction-The-toxin.tif

 

https://www.researchgate.net/publication/326418386/figure/fig1/AS%3A649001649074176%401531745459361/Molecular-model-of-synaptic-vesicle-fusion-machinery-interactions-of-active-zone.png

 

https://www.researchgate.net/publication/11601496/figure/fig1/AS%3A276992743231488%401443051624270/Mode-of-action-of-botulinum-neurotoxins-at-the-neuromuscular-junction-A-The-neurotoxin.png

🔹 CONGENITAL MYASTHENIC SYNDROMES

🔸 Definition

  • Genetic disorders affecting neuromuscular transmission

🔸 Mechanism

  • Defects in:

    • ACh receptors

    • Synaptic proteins

    • Enzymes involved in transmission

🔹 CLINICAL FEATURES

  • Muscle weakness from birth

  • Non-autoimmune

🧠 KEY HIGH-YIELD POINTS

  • Lambert-Eaton → presynaptic Ca²⁺ channel defect

  • Botulism → toxin blocks ACh release

  • Drug-induced → reversible NM blockade

  • Congenital → genetic defects in transmission

 

🔷 DISORDERS OF SKELETAL MUSCLE

🔹 CLASSIFICATION OF MYOPATHIES

🔸 Inherited (Genetic)

  • Muscular dystrophies

    • Duchenne muscular dystrophy

    • Becker muscular dystrophy

  • Congenital myopathies

  • Metabolic myopathies

    • Glycogen storage diseases

    • Mitochondrial myopathies

  • Channelopathies

🔸 Acquired

  • Inflammatory myopathies

    • Polymyositis

    • Dermatomyositis

    • Inclusion body myositis

  • Toxic myopathies

    • Alcohol

    • Drugs (statins, steroids)

  • Endocrine myopathies

    • Thyroid disorders

    • Cushing syndrome

🔹 GENERAL PATHOLOGY OF SKELETAL MUSCLE

🔸 Patterns of muscle fiber injury

  • Muscle fiber necrosis

  • Degeneration and regeneration

  • Atrophy

  • Hypertrophy

🔸 Morphological changes

  • Variation in fiber size

  • Central nuclei in regenerating fibers

  • Fiber splitting

  • Fatty replacement in chronic disease

🔸 Ultrastructural changes

  • Z-line disruption

  • Mitochondrial abnormalities

  • Increased serum creatine kinase

🔸 Functional effects

  • Weakness of affected muscles

  • Reduced endurance

  • Progressive disability in chronic conditions

📊 TABLE: CLASSIFICATION OF MYOPATHIES

Category Types Examples
Inherited Muscular dystrophies Duchenne, Becker
  Metabolic myopathies Glycogen storage disease
  Channelopathies Periodic paralysis
Acquired Inflammatory Polymyositis, Dermatomyositis
  Toxic Alcohol, drugs
  Endocrine Thyroid myopathy

🧠 KEY HIGH-YIELD POINTS

  • Inherited → genetic defects in muscle proteins

  • Acquired → inflammatory, toxic, endocrine causes

  • Necrosis + regeneration → hallmark of muscle injury

  • Fatty replacement → chronic myopathy

  • CK levels ↑ in muscle damage

 

🔷 PATTERNS OF SKELETAL MUSCLE INJURY

🔹 MUSCLE FIBER NECROSIS

🔸 Definition

  • Irreversible injury leading to muscle fiber destruction

🔸 Causes

  • Ischemia

  • Toxins

  • Inflammatory myopathies

  • Trauma

🔸 Morphology

  • Loss of cross-striations

  • Cytoplasmic eosinophilia

  • Fragmentation of fibers

  • Inflammatory cell infiltration

🔹 REGENERATION (SATELLITE CELLS)

🔸 Mechanism

  • Satellite cells (muscle stem cells) activated after injury

  • Proliferation → differentiation into myoblasts

  • Fusion → formation of new muscle fibers

🔸 Features

  • Central nuclei in regenerating fibers

  • Basophilic cytoplasm

  • Requires intact basal lamina

🧠 DIAGRAM: MUSCLE REGENERATION

Image

Image

Image

Image

🔹 Concept (Exam-Oriented)

  • Injury → activation of satellite cells (muscle stem cells)

  • Satellite cells proliferate → form myoblasts

  • Myoblasts fuse → new muscle fibers

  • Regenerated fibers show central nuclei

🔹 Key Points

  • Requires intact basal lamina

  • Guided regeneration → normal architecture restored

  • Severe damage → fibrosis instead of regeneration

🔹 Flow Concept

Muscle injury
↓
Satellite cell activation
↓
Myoblast proliferation
↓
Fusion into myotubes
↓
Maturation into muscle fibers
↓
Functional recovery

🔹 ATROPHY

🔸 Definition

  • Reduction in muscle fiber size

🔸 Types

🔹 Denervation atrophy

  • Loss of nerve supply

  • Rapid muscle wasting

🔹 Disuse atrophy

  • Reduced physical activity

  • Gradual muscle loss

🔹 HYPERTROPHY

🔸 Definition

  • Increase in muscle fiber size

🔸 Causes

  • Increased workload

  • Hormonal influence

🔹 FIBER TYPE CHANGES

🔸 Types of fibers

  • Type I (slow-twitch, oxidative)

  • Type II (fast-twitch, glycolytic)

🔸 Changes

  • Fiber type grouping (denervation–reinnervation)

  • Selective fiber atrophy

🔹 ULTRASTRUCTURAL CHANGES

🔸 Z-line disruption

  • Loss of sarcomere integrity

🔸 Mitochondrial damage

  • Impaired energy production

🔸 Biochemical marker

  • Increased serum creatine kinase

📊 TABLE: NECROSIS vs ATROPHY vs HYPERTROPHY

Feature Necrosis Atrophy Hypertrophy
Cell size Decreased (due to destruction) Decreased Increased
Reversibility Irreversible Reversible Reversible
Cause Injury Disuse/denervation Increased workload
Outcome Cell death Reduced function Increased function

🧠 FLOWCHART: MUSCLE INJURY → REPAIR

Muscle injury
↓
Muscle fiber necrosis
↓
Inflammation
↓
Satellite cell activation
↓
Myoblast proliferation
↓
Fusion into new fibers
↓
Regeneration OR fibrosis (if severe damage)

🔬 SLIDES (EXAM FAVORITE)

🔹 Necrotic Muscle Fibers

Image

Image

Image

  • Loss of striations

  • Eosinophilic cytoplasm

  • Fragmented fibers

  • Inflammatory infiltrates

🔹 Regenerating Muscle Fibers

Image

 

Image

 

  • Central nuclei

  • Basophilic cytoplasm

  • Smaller fibers compared to normal

🧠 KEY HIGH-YIELD POINTS

  • Necrosis → irreversible muscle injury

  • Regeneration → satellite cell mediated

  • Atrophy → decreased size (denervation/disuse)

  • Hypertrophy → increased size

  • Fiber type grouping → denervation sign

  • Creatine kinase → marker of muscle damage

 

🔷 INHERITED DISORDERS OF SKELETAL MUSCLE

🔹 MUSCULAR DYSTROPHIES

🔸 Definition

  • Group of genetic disorders characterized by progressive muscle degeneration and weakness

  • Due to defects in structural muscle proteins

🔹 DUCHENNE MUSCULAR DYSTROPHY (DMD)

🔸 Genetics

  • X-linked recessive inheritance

  • Mutation in dystrophin gene (Xp21)

🔸 Pathogenesis

  • Absence of dystrophin → fragile sarcolemma

  • Muscle fiber damage during contraction

  • Repeated cycles of degeneration and regeneration

  • Replacement by fat and connective tissue

🔸 Key features

  • Onset in early childhood

  • Progressive muscle weakness (proximal muscles first)

  • Calf pseudohypertrophy

  • Gowers’ sign

  • Markedly increased serum creatine kinase

🧠 Diagram: Dystrophin Function

Image

Image

Image

Image

🔹 BECKER MUSCULAR DYSTROPHY

🔸 Genetics

  • X-linked recessive

  • Partial deficiency of dystrophin

🔸 Features

  • Milder than DMD

  • Later onset

  • Slower progression

🔹 CHANNELOPATHIES

🔸 Definition

  • Disorders caused by mutations in ion channels

🔸 Examples

  • Periodic paralysis

  • Myotonia congenita

🔹 METABOLIC MYOPATHIES

🔸 Definition

  • Defects in energy metabolism of muscle

🔸 Examples

  • Glycogen storage diseases

  • Mitochondrial myopathies

📊 TABLE: DMD vs BECKER MUSCULAR DYSTROPHY

Feature Duchenne MD Becker MD
Inheritance X-linked recessive X-linked recessive
Dystrophin Absent Reduced
Onset Early childhood Adolescence/adulthood
Severity Severe Mild
Progression Rapid Slow
CK levels Very high Moderately high

📊 TABLE: TYPES OF INHERITED MYOPATHIES

Category Examples
Muscular dystrophies Duchenne, Becker
Channelopathies Periodic paralysis
Metabolic myopathies Glycogen storage disease
Congenital myopathies Structural defects

🧠 FLOWCHART: DYSTROPHIN MUTATION → MUSCLE DAMAGE

Dystrophin gene mutation
↓
Absence of dystrophin
↓
Weak sarcolemma
↓
Muscle fiber injury during contraction
↓
Repeated degeneration
↓
Fatty replacement + fibrosis
↓
Progressive muscle weakness

🔬 SLIDES (EXAM FAVORITE)

🔹 Muscle Degeneration + Fatty Replacement

Image

Image

Image

Image

  • Variation in fiber size

  • Muscle fiber degeneration

  • Fatty infiltration and fibrosis

  • Loss of normal architecture

🧠 KEY HIGH-YIELD POINTS

  • DMD → absence of dystrophin

  • X-linked inheritance

  • Early onset and severe progression

  • CK markedly increased

  • Calf pseudohypertrophy

  • Becker → milder variant with partial dystrophin deficiency

 

 

🔷 ACQUIRED DISORDERS OF SKELETAL MUSCLE

🔹 INFLAMMATORY MYOPATHIES

🔸 Polymyositis

🔹 Pathogenesis

  • CD8+ T-cell mediated muscle fiber injury

  • Direct cytotoxic effect on muscle fibers

🔹 Features

  • Symmetrical proximal muscle weakness

  • No skin involvement

  • Elevated creatine kinase

🔹 Morphology

  • Endomysial inflammation

  • Muscle fiber necrosis

  • Regeneration

🔸 Dermatomyositis

🔹 Pathogenesis

  • CD4+ T-cell + complement-mediated microangiopathy

  • Immune complex deposition in vessels → ischemic injury

🔹 Features

  • Proximal muscle weakness

  • Skin manifestations

    • Heliotrope rash

    • Gottron papules

🔹 Morphology

  • Perifascicular atrophy

  • Perivascular inflammation

🧠 Diagram: Perifascicular Atrophy

Image

Image

Image

Image

🔸 Inclusion Body Myositis

🔹 Features

  • Slowly progressive muscle weakness

  • Affects both proximal and distal muscles

  • More common in elderly

🔹 Morphology

  • Muscle fiber degeneration

  • Inclusion bodies within fibers

🔹 TOXIC MYOPATHIES

🔸 Causes

  • Alcohol

  • Drugs (statins, steroids)

🔸 Features

  • Muscle weakness

  • Myalgia

  • Elevated creatine kinase

🔹 ENDOCRINE MYOPATHIES

🔸 Causes

  • Hyperthyroidism

  • Hypothyroidism

  • Cushing syndrome

🔸 Features

  • Proximal muscle weakness

  • Variable severity

📊 TABLE: POLYMYOSITIS vs DERMATOMYOSITIS

Feature Polymyositis Dermatomyositis
Immune mechanism CD8+ T-cell mediated CD4+ + complement-mediated
Muscle involvement Direct muscle fiber injury Vascular-mediated injury
Inflammation site Endomysial Perivascular
Skin involvement Absent Present
Characteristic feature Muscle necrosis Perifascicular atrophy

🧠 FLOWCHART: AUTOIMMUNE MUSCLE INJURY

Autoimmune trigger
↓
Activation of immune cells
↓
CD8+ T-cell attack (polymyositis)
OR
CD4+ + complement-mediated vascular injury (dermatomyositis)
↓
Muscle fiber damage
↓
Inflammation
↓
Muscle weakness

🔬 SLIDES (EXAM FAVORITE)

🔹 Dermatomyositis (Perifascicular Atrophy)

Image

Image

Image

Image

  • Atrophy of muscle fibers at periphery of fascicles

  • Perivascular inflammation

  • Ischemic injury pattern

🔹 Polymyositis (Endomysial Inflammation)

Image

Image

Image

Image

  • Endomysial inflammatory infiltrate

  • Muscle fiber necrosis

  • CD8+ T-cell involvement

🧠 KEY HIGH-YIELD POINTS

  • Polymyositis → CD8+ T-cell mediated muscle injury

  • Dermatomyositis → complement-mediated vascular damage

  • Perifascicular atrophy → hallmark of dermatomyositis

  • Endomysial inflammation → polymyositis

  • Inclusion body myositis → elderly, slow progression

  • CK levels increased in inflammatory myopathies

 

 

🔷 PERIPHERAL NERVE SHEATH TUMORS

🔹 CLASSIFICATION

🔸 Based on behavior

  • Benign

    • Schwannoma

    • Neurofibroma

  • Malignant

    • Malignant peripheral nerve sheath tumor (MPNST)

🔸 Origin

  • Arise from Schwann cells and nerve sheath components

📊 TABLE: CLASSIFICATION OF NERVE SHEATH TUMORS

Category Tumors
Benign Schwannoma, Neurofibroma
Malignant MPNST

🔷 SCHWANNOMAS AND NF TYPE 2

🔹 DEFINITION

  • Benign tumor arising from Schwann cells

  • Typically involves peripheral nerves

🔹 PATHOGENESIS

🔸 Genetic basis

  • Mutation in NF2 gene (chromosome 22)

  • Loss of tumor suppressor protein (merlin)

🔹 MORPHOLOGY

🔸 Gross features

  • Well-encapsulated tumor

  • Eccentric to nerve (pushes nerve aside)

🔸 Microscopic features

  • Antoni A areas

    • Dense cellular areas

    • Spindle cells arranged in fascicles

    • Nuclear palisading

  • Antoni B areas

    • Loose, myxoid areas

    • Less cellular

📊 TABLE: ANTONI A vs ANTONI B AREAS

Feature Antoni A Antoni B
Cellularity High Low
Arrangement Compact, organized Loose, disorganized
Stroma Minimal Myxoid
Nuclear pattern Palisading No palisading

🧠 Diagram: Schwannoma Architecture

Image

Image

Image

 

🔹 CLINICAL FEATURES

  • Slow-growing mass

  • May cause nerve compression symptoms

  • Associated with Neurofibromatosis type 2

    • Bilateral vestibular schwannomas (classic feature)

🔬 SLIDES (EXAM FAVORITE)

🔹 Verocay Bodies

Image

Image

 

  • Nuclear palisading of Schwann cells

  • Alternating nuclear and anuclear zones

  • Seen in Antoni A areas

  • Characteristic feature of schwannoma

🧠 KEY HIGH-YIELD POINTS

  • Schwannoma → benign, encapsulated tumor

  • NF2 mutation → loss of merlin

  • Antoni A → dense, palisading nuclei

  • Antoni B → loose, myxoid

  • Verocay bodies → diagnostic feature

  • Tumor grows eccentric to nerve

 

🔷 NEUROFIBROMAS

🔹 DEFINITION

  • Benign peripheral nerve sheath tumor
  • Composed of mixed cellular elements derived from nerve sheath

🔹 TYPES

🔸 Localized neurofibroma

  • Solitary lesion
  • Well-defined but non-encapsulated
  • Most common type

🔸 Diffuse neurofibroma

  • Infiltrative growth pattern
  • Commonly involves skin and subcutaneous tissue

🔸 Plexiform neurofibroma

  • Involves multiple nerve fascicles
  • Produces “bag of worms” appearance
  • Strong association with Neurofibromatosis type 1 (NF1)
  • Risk of malignant transformation

🧠 Diagram: Plexiform Neurofibroma

https://www.researchgate.net/publication/254261209/figure/fig5/AS%3A297973406814230%401448053804813/Bag-of-worms-sign-in-a-superficial-plexiform-neurofibroma-Coronal-3D-fat-suppressed.png

https://www.researchgate.net/publication/336832002/figure/fig5/AS%3A850542733582338%401579796598538/A-schematic-representation-of-neurofibromas-in-NF1-patients-Neurofibromas-are-known-to.ppm

https://www.researchgate.net/publication/333239337/figure/fig2/AS%3A894408878731266%401590255102466/Plexiform-neurofibroma-of-the-tongue-with-multiple-adjacent-nerve-bundles-expanded-by.png

4

🔹 ASSOCIATION WITH NF1

  • Common tumor in Neurofibromatosis type 1
  • May be multiple
  • Plexiform type is diagnostic of NF1

🔹 CELL COMPOSITION

  • Schwann cells
  • Fibroblasts
  • Perineurial cells
  • Mast cells

🔬 MORPHOLOGY

🔸 Gross

  • Soft, poorly defined mass
  • Non-encapsulated
  • Expands nerve

🔸 Microscopy

  • Spindle-shaped cells with wavy nuclei
  • Loose collagenous matrix
  • Mixed cellular population

📊 TABLE: SCHWANNOMA vs NEUROFIBROMA

Feature Schwannoma Neurofibroma
Capsule Present Absent
Relation to nerve Eccentric Within nerve
Cell type Pure Schwann cells Mixed cell population
NF association NF2 NF1
Growth pattern Well-circumscribed Infiltrative

🔬 SLIDES (EXAM FAVORITE)

🔹 Mixed Cell Tumor (Neurofibroma)

https://www.mdpi.com/dermatopathology/dermatopathology-10-00001/article_deploy/html/images/dermatopathology-10-00001-g011.png

https://www.researchgate.net/publication/46392692/figure/fig2/AS%3A195782134243329%401423689506491/Microscopic-findings-of-the-tumor-a-Fibrous-and-cellular-components-of-the-tumor-b.png

https://www.researchgate.net/publication/380018959/figure/fig1/AS%3A11431281242262022%401715407331326/Examples-of-various-histopathologic-types-of-peripheral-nerve-sheath-tumors-in-NF1-as.jpg

4

  • Spindle-shaped cells with wavy nuclei
  • Mixed cellular population
  • Loose collagen matrix
  • Absence of capsule

🧠 KEY HIGH-YIELD POINTS

  • Neurofibroma → benign mixed nerve sheath tumor
  • Non-encapsulated and infiltrative
  • Plexiform type → diagnostic of NF1
  • “Bag of worms” appearance
  • Mixed cells → Schwann + fibroblasts + mast cells
  • Risk of malignant transformation (especially plexiform type)

 

 

🔷 MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)

🔹 DEFINITION

  • Aggressive malignant tumor arising from peripheral nerve sheath
  • Derived from Schwann cells or pluripotent neural crest cells

🔹 ASSOCIATION WITH NF1

  • Strong association with Neurofibromatosis type 1 (NF1)
  • Often arises from pre-existing plexiform neurofibroma
  • Higher risk of malignancy in NF1 patients

🔹 MORPHOLOGY

🔸 Gross features

  • Poorly circumscribed mass
  • Infiltrative growth into surrounding tissues
  • Areas of hemorrhage and necrosis

🔸 Microscopic features

  • Spindle-shaped malignant cells
  • High mitotic activity
  • Necrosis present
  • Infiltrative growth pattern
  • Cellular atypia and pleomorphism

🔹 CLINICAL FEATURES

  • Rapidly enlarging mass
  • Pain or neurological deficits
  • Often deep-seated tumors
  • Poor prognosis

📊 TABLE: BENIGN vs MALIGNANT NERVE TUMORS

Feature Benign (Schwannoma/Neurofibroma) Malignant (MPNST)
Growth Slow Rapid
Capsule Present/absent (well-defined) Absent
Margins Well-circumscribed Infiltrative
Mitosis Rare Frequent
Necrosis Absent Present
Prognosis Good Poor

🔬 SLIDES (EXAM FAVORITE)

🔹 Spindle Cell Malignancy

https://www.pathologyoutlines.com/imgau/stmpnstmicro02.png

https://www.researchgate.net/publication/6649376/figure/fig1/AS%3A394723803058182%401471120896546/Malignant-peripheral-nerve-sheath-tumor-Malignant-spindle-cells-with-marked-pleomorphism.png

https://www.researchgate.net/publication/359386493/figure/fig5/AS%3A1147124767039501%401650507265717/Malignant-peripheral-nerve-sheath-tumor-is-a-fascicular-spindle-cell-sarcoma-often_Q320.jpg

4

  • Spindle-shaped malignant cells
  • Marked cellular atypia
  • Increased mitotic figures
  • Areas of necrosis
  • Infiltrative tumor pattern

🧠 KEY HIGH-YIELD POINTS

  • MPNST → malignant nerve sheath tumor
  • Strong association with NF1
  • Arises from plexiform neurofibroma
  • Spindle cell morphology
  • High mitotic activity and necrosis
  • Poor prognosis

 

🔷 NEUROFIBROMATOSIS TYPE I (NF1)

🔹 GENETICS

  • Mutation in NF1 gene (chromosome 17)

  • Encodes neurofibromin (tumor suppressor protein)

  • Autosomal dominant inheritance

  • High rate of new (de novo) mutations

🔹 PATHOGENESIS

  • Loss of neurofibromin → increased RAS signaling

  • Uncontrolled cell proliferation

  • Development of multiple tumors, especially nerve sheath tumors

🧠 FLOWCHART: NF1 MUTATION → TUMOR FORMATION

NF1 gene mutation
↓
Loss of neurofibromin
↓
Increased RAS pathway activation
↓
Uncontrolled cell proliferation
↓
Development of neurofibromas and other tumors

🔹 CLINICAL FEATURES

🔸 Skin manifestations

  • Café-au-lait spots

    • Light brown macules

    • ≥6 lesions diagnostic

  • Axillary/inguinal freckling

🔸 Ocular findings

  • Lisch nodules

    • Pigmented iris hamartomas

🔸 Neural tumors

  • Multiple neurofibromas

  • Plexiform neurofibroma (pathognomonic)

🔸 CNS tumors

  • Optic glioma

🧠 Diagram: Café-au-lait Lesions

Image

Image

Image

🔹 COMPLICATIONS

  • Malignant transformation → MPNST

  • Skeletal abnormalities

  • Learning disabilities

  • Increased risk of other tumors

📊 TABLE: NF1 vs NF2

Feature NF1 NF2
Gene NF1 (chr 17) NF2 (chr 22)
Protein Neurofibromin Merlin
Main tumors Neurofibromas Schwannomas
Skin findings Café-au-lait spots Minimal
Eye findings Lisch nodules Cataracts
CNS tumors Optic glioma Bilateral vestibular schwannomas

🧠 KEY HIGH-YIELD POINTS

  • NF1 → autosomal dominant disorder

  • Mutation in neurofibromin → RAS activation

  • Café-au-lait spots (≥6 diagnostic)

  • Axillary freckling

  • Lisch nodules

  • Plexiform neurofibroma → characteristic

  • Risk of MPNST

 

🔷 TRAUMATIC NEUROMA

🔹 DEFINITION

  • Non-neoplastic lesion resulting from reactive proliferation of nerve tissue after injury

  • Represents disorganized regeneration of severed nerve fibers

🔹 PATHOGENESIS

🔸 Mechanism

  • Nerve injury or transection

  • Proximal nerve stump attempts regeneration

  • Lack of proper alignment with distal segment

  • Disorganized proliferation of axons, Schwann cells, and connective tissue

  • Formation of a nodular mass (neuroma)

🧠 Diagram: Disorganized Nerve Regeneration

Image

Image

Image

Image

🔹 CLINICAL FEATURES

  • Small nodular lesion at site of prior injury

  • Often occurs after surgery or trauma

  • Painful lesion, especially on pressure

  • May cause localized tenderness

🔬 SLIDES (EXAM FAVORITE)

🔹 Tangled Nerve Fibers

Image

Image

 

Image

  • Disorganized bundles of nerve fibers

  • Proliferation of Schwann cells

  • Fibrous connective tissue

  • No true neoplastic features

🧠 KEY HIGH-YIELD POINTS

  • Not a true tumor → reactive lesion

  • Occurs after nerve injury

  • Disorganized regeneration of axons

  • Painful nodular swelling

  • Histology → tangled nerve fibers with fibrosis

 

 

🔧 ADDITIONAL HIGH-YIELD DIAGRAMS (FINAL COMPLETION)

🧠 DIAGRAM: NF2 TUMOR PATHWAY

NF2 gene mutation
↓
Loss of merlin (tumor suppressor protein)
↓
Uncontrolled Schwann cell proliferation
↓
Schwannoma formation
↓
Bilateral vestibular schwannomas

🧠 INTEGRATED MASTER DIAGRAM (VERY HIGH-YIELD REVISION TOOL)

Nerve injury
↓
Axonal degeneration / demyelination
↓
Neuromuscular junction dysfunction
↓
Muscle fiber damage
↓
Atrophy / regeneration / fibrosis

 

  • NF2 tumor pathway diagram → Added

  • Integrated nerve → muscle pathway → Added

 

 

 

Ready to study offline?

Get the full PDF version of this chapter.

Preview & Download
Back to Topics